Literature DB >> 12238647

Seroprevalence of hepatitis A immunity in male genitourinary medicine clinic attenders: a case control study of heterosexual and homosexual men.

J D C Ross1, M Ghanem, A Tariq, G Gilleran, A J Winter.   

Abstract

OBJECTIVES: To compare the seroprevalence of hepatitis A in homosexual and heterosexual men to determine their susceptibility to infection and provide guidance for a policy on vaccination.
METHODS: A case-control study design was utilised to compare the risk factors associated with hepatitis A in homosexual and heterosexual men attending a city centre genitourinary medicine clinic. Demographic and sexual behavioural characteristics were included in univariate and multivariate models.
RESULTS: The overall seropositivity rate was 29% with no significant difference between homosexual and heterosexual men. Ethnicity and age were strongly associated with hepatitis A seropositivity in both homosexuals and heterosexuals. A history of sex in a sauna in homosexual men, and being born outside the United Kingdom for heterosexual men, was associated with hepatitis A seropositivity.
CONCLUSIONS: Targeted hepatitis A screening and vaccination of homosexual men attending UK genitourinary medicine clinics is not supported by the results of this study.

Entities:  

Mesh:

Year:  2002        PMID: 12238647      PMCID: PMC1744479          DOI: 10.1136/sti.78.3.174

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  24 in total

1.  Venereal transmission of enteric pathogens in male homosexuals. Two case reports.

Authors:  D Mildvan; A M Gelb; D William
Journal:  JAMA       Date:  1977-09-26       Impact factor: 56.272

2.  Prevalence and incidence of hepatitis A among male homosexuals.

Authors:  R A Coutinho; P Albrecht-van Lent; N Lelie; N Nagelkerke; H Kuipers; T Rijsdijk
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-10

3.  [Serologic markers of hepatitis A and B in male homosexuals].

Authors:  M Brugera; J M Sánchez Tapias; X Latorre; J M Miró
Journal:  Med Clin (Barc)       Date:  1984-12-15       Impact factor: 1.725

Review 4.  An epidemic of acute viral hepatitis in male homosexuals. Etiology and clinical characteristics.

Authors:  G Høybye; P Skinhøj; B Hentzer; V Faber; L Mathiesen
Journal:  Scand J Infect Dis       Date:  1980

5.  Syphilis, hepatitis A, hepatitis B, and cytomegalovirus infection in homosexual men in Antwerp.

Authors:  C H Coester; D Avonts; J Colaert; J Desmyter; P Piot
Journal:  Br J Vener Dis       Date:  1984-02

6.  Antibodies to hepatitis A antigen in relation to the number of lifetime sexual partners in patients attending an STD clinic.

Authors:  E S McFarlane; J A Embil; F R Manuel; H J Thiébaux
Journal:  Br J Vener Dis       Date:  1981-02

7.  Sexual transmission of hepatitis A in homosexual men: incidence and mechanism.

Authors:  L Corey; K K Holmes
Journal:  N Engl J Med       Date:  1980-02-21       Impact factor: 91.245

Review 8.  Viral hepatitis in a venereal clinic population. Relation to certain risk factors.

Authors:  B Hentzer; P Skinhøj; G Høybye; A O Nielsen; S A Kvorning; V Faber
Journal:  Scand J Infect Dis       Date:  1980

9.  Increased risk of infection with hepatitis A and B viruses in men with a history of syphilis: relation to sexual contacts.

Authors:  P Kryger; N S Pedersen; L Mathiesen; J O Nielsen
Journal:  J Infect Dis       Date:  1982-01       Impact factor: 5.226

10.  Prevalence of antibodies to hepatitis A antigen in patients attending a clinic for treatment of sexually transmitted diseases.

Authors:  E S McFarlane; J A Embil; F R Manuel; M Gorelick
Journal:  Sex Transm Dis       Date:  1980 Apr-Jun       Impact factor: 2.830

View more
  1 in total

Review 1.  Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review.

Authors:  Kuan-Yin Lin; Guan-Jhou Chen; Yu-Lin Lee; Yi-Chia Huang; Aristine Cheng; Hsin-Yun Sun; Sui-Yuan Chang; Chun-Eng Liu; Chien-Ching Hung
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.